Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Disclosure of Interest/ Changes in Interest of Director - Albert Ho Shing Tung

Issuer & Securities

Issuer/ Manager: IX BIOPHARMA LTD.
Securities: IX BIOPHARMA LTD. - SG1BD9000009 - 42C
IX BIOPHARMA LTD. W260718 - SGXN57296778 - HQXW
Stapled Security: No

Announcement Title: Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer
Date &Time of Broadcast: 22-Jul-2024 19:44:25
Status: New
Announcement Sub Title: Disclosure of Interest/ Changes in Interest of Director - Albert Ho Shing Tung
Announcement Reference: SG240722OTHRDZ1S
Submitted By (Co./ Ind. Name): Gwendolin Lee Soo Fern
Designation: Company Secretary
Description (Please provide a detailed description of the event in the box below - Refer to the Online help for the format): Please see attached.

This announcement has been reviewed by the Company's sponsor, UOB Kay Hian Private Limited (the "Sponsor"). It has not been examined or approved by the Singapore Exchange Securities Trading Limited (the "Exchange") and the Exchange assumes no responsibility for the contents of this announcement, including the correctness of any of the statements or opinions made or reports contained in this announcement.

The contact person for the Sponsor is Mr. Lance Tan, Senior Vice President, at 8 Anthony Road, #01-01, Singapore 229957, telephone (65) 6590 6881.

Person(s) giving notice: Director/Chief Executive Officer who may also be a substantial shareholder/unitholder (Form 1)
Date of receipt of notice by Listed Issuer: 19/07/2024

if you are unable to view the above file, please click the link below.

Total size =148K